Investors will be watching what information UnitedHealth shares related to COVID-19 medical costs, including testing and hospitalizations, as well as how the cancellation of nonemergency care is reflected in the healthcare giant’s results. However, COVID-19 medical costs aren’t expected to significantly affect UnitedHealth’s first-quarter results, since COVID-19 testing and infections became much more prevalent late in the quarter in March, according to the report.
In a note to clients cited by CNBC, analysts at Piper Sandler said early data on medical claims may be unclear, as “much of the claims processing/coding teams [are] now working from home at hospitals and insurers,” which could slow normal revenue cycle processes.
UnitedHealth is expected to report adjusted earnings of $3.63 per share on $64.4 billion in revenue for the first quarter of 2020, according to CNBC, which cites an estimate from Refinitiv.
More articles on healthcare finance:
105 hospitals furloughing workers in response to COVID-19
Mayo Clinic projects $900M shortfall, implements cost-cutting measures
State-by-state breakdown of 354 rural hospitals at high risk of closing
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.